Search

everythinglearnresearchcommunity

for

Search:↓

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Managing PCOS is hard because it varies a lot, treatments are limited, and there's a lot of false information online.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.